Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · Real-Time Price · USD
25.21
+0.19 (0.78%)
At close: Oct 2, 2026, 4:00 PM EDT
25.21
+0.01 (0.02%)
After-hours: Oct 2, 2026, 4:15 PM EDT
Pacira BioSciences Market Cap
Pacira BioSciences has a market cap or net worth of $1 billion as of October 2, 2026. Its market cap has decreased by -11.51% in one year.
Market Cap
1.00B
Enterprise Value
1.17B
1-Year Change
-11.51%
Ranking
Category
Stock Price
$25.21
ChartMarket Cap Chart
Since February 3, 2011, Pacira BioSciences's market cap has increased from $121.00M to $1.00B, an increase of 730.35%. That is a compound annual growth rate of 14.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 1.00B | -9.76% |
| Dec 31, 2025 | 1.11B | 27.99% |
| Dec 31, 2024 | 869.90M | -44.48% |
| Dec 29, 2023 | 1.57B | -11.56% |
| Dec 30, 2022 | 1.77B | -33.90% |
| Dec 31, 2021 | 2.68B | 3.10% |
| Dec 31, 2020 | 2.60B | 37.52% |
| Dec 31, 2019 | 1.89B | 6.88% |
| Dec 31, 2018 | 1.77B | -4.50% |
| Dec 29, 2017 | 1.85B | 53.30% |
| Dec 30, 2016 | 1.21B | -57.20% |
| Dec 31, 2015 | 2.82B | -11.70% |
| Dec 31, 2014 | 3.20B | 65.79% |
| Dec 31, 2013 | 1.93B | 239.05% |
| Dec 31, 2012 | 568.70M | 281.68% |
| Dec 30, 2011 | 149.00M | 23.14% |
| Feb 3, 2011 | 121.00M | - |
View and export this data all the way back to 2011. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xeris Biopharma Holdings | 1.70B |
| ANI Pharmaceuticals | 1.57B |
| Eton Pharmaceuticals | 1.49B |
| Phibro Animal Health | 1.46B |
| Cronos Group | 1.22B |
| Harrow | 1.16B |
| Amphastar Pharmaceuticals | 1.08B |
| Collegium Pharmaceutical | 719.80M |